Accolade, Inc. (ACCD)
NASDAQ: ACCD · IEX Real-Time Price · USD
4.080
+0.230 (5.97%)
At close: Jul 26, 2024, 4:00 PM
4.110
+0.030 (0.74%)
After-hours: Jul 26, 2024, 7:16 PM EDT
Accolade Market Cap
Accolade has a market cap or net worth of $326.43 million as of July 26, 2024. Its market cap has decreased by -68.34% in one year.
Market Cap
326.43M
Enterprise Value
327.99M
1-Year Change
-68.34%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $326.43M, a decrease of -76.61%. That is a compound annual growth rate of -30.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 308.00M | -66.36% |
| Dec 29, 2023 | 915.50M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -18.04% |
| Dec 31, 2020 | 2.14B | 53.60% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 303.23M |
| SOPHiA GENETICS | 302.03M |
| Opthea | 300.29M |
| Verrica Pharmaceuticals | 299.49M |
| Aquestive Therapeutics | 299.06M |
| Nyxoah | 297.39M |
| MeiraGTx Holdings | 295.81M |
| MultiPlan | 295.76M |